Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal and cardiac effects of terlipressin and dobutamine in cirrhosis and ascites
2012-002275-33Phase 4Completed
- Sponsor
- University Hospital Odense, Department of Gastroenterology
- Start
- Jan 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin, dobutamine in hepatorenal syndrome (HRS), Cirrhosis, ascites, sponsored by University Hospital Odense, Department of Gastroenterology. Started Jan 2014; status: completed.
02
Drugs
terlipressindobutamine
03
Conditions
hepatorenal syndrome (HRS)Cirrhosisascites
Beyond the preview
Go deeper on 2012-002275-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002275-33.